Pacira | PCRX - 营业费用

股票价格

22.35

每天变化

0.04 0.18%

每月一次

-10.24%

每年

-16.45%

Q2 预测

22.18

金融业

USD

USD 1.21B

现金及等价物

USD 144.31M

USD 50.74M

USD 514.96M

USD 108.79M

USD 367.66M

USD 4.63M

USD 40.24M

790

EPS每股收益

USD 0.6

股本和储备

USD 653.89M

USD 126.64M

债务利息支出

USD 3.7M

USD 2.3M

USD 367.66M

USD 1.04B

USD 2.92M

USD 172.75M

USD 4.63M

普通股股本

USD 39.31M

38.58

USD 571K

USD 177M

销售和管理费用

USD 83.88M

USD 150.37M

贸易债权人

USD 14.01M

应收帐款人

USD 125.64M

	营业费用	更改		日
Assertio Holdings	USD 105.8M		12.5M	2025-09
Astellas Pharma	JPY 489.36B		52.69B	2026-03
Bristol-Myers Squibb	USD 20.07B		11.77B	2026-03
Cara Therapeutics	USD 5.94M		983K	2025-09
Coherus Biosciences	USD 51.83M		2.48M	2025-12
Heron Therapeutics	USD 40.55M		1.46M	2025-12
Ironwood Pharmaceuticals	USD 57.33M		8.63M	2024-12
J&J	USD 17.44B		1.53B	2026-03
Ligand Pharmaceuticals	USD 34.35M		5.27M	2026-03
Nektar Therapeutics	USD 40.9M		44.19M	2025-12
Novo Nordisk	DKK 37.21B		9.56B	2026-03
Omeros	USD 59.16M		20.13M	2024-06
Pacira	USD 172.75M		20.93M	2026-03
Perrigo	USD 935.6M		89.6M	2026-03
Pfizer	USD 90.1B		77.19B	2026-03
Supernus Pharmaceuticals	USD 1.08B		879.06M	2026-03
Teva Pharmaceutical Industries	USD 3.22B		1000M	2026-03
Xeris Pharmaceuticals	USD 69.03M		1.38M	2025-12
Xoma	USD 22.84M		1.67M	2024-09
Zoetis	USD 3.23B		1.68B	2026-03